Deliver Your News to the World

SmallCapNewsRelease:(OTCBB: POSC) Subsidiary To Collaborate With ARRONAX


JERICHO, NY—(SmallCapNewsRelease)—November 17, 2011, Positron Corp. (OTCBB: POSC) a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce that Manhattan Isotope Technology (MIT), with the support of Positron, has executed a Memorandum of Understanding with the ARRONAX Cyclotron Facility in Nantes, France.
Positron Corporation is a leading molecular imaging company providing innovative nuclear medicine technologies and services that are reshaping the field of nuclear cardiology. Through proprietary PET imaging systems and radiopharmaceutical solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes while practicing cost effective medicine.
ARRONAX has made a critical investment for increasing the global supply of medical radioisotopes. ARRONAX is one of only a small number of global accelerator facilities which possess the requisite proton beam characteristics for strontium-82 production.
MIT LLC President, Jason Kitten commented upon the significance of the MOU, “Working with the high caliber scientists at ARRONAX and their cutting-edge high power cyclotron is truly a tremendous growth opportunity for Sr-82 supply. We fully expect that the collaboration of ARRONAX and MIT will expand the global supply of Sr-82; a supply that is very limited and in great demand by the medical community.”
SmallCapNewsRelease gainers are Valpey Fisher Corp (NASDAQ: VPF) Sino Clean Energy (NASDAQ: SCEI) Angie’s List (NASDAQ: ANGI) Zoll Medical Corp (NASDAQ: ZOLL) Rambus, Inc (NASDAQ: RMBS) Acco Brands Corp (NYSE: ABD) Viasystems Group (NASDAQ: VIAS) Sanofi (NASDAQ: GCVRZ)
SmallCapNewsRelease decliners are Perry Ellis International (NASDAQ: PERY) ZipRealty (NASDAQ: ZIPR) Carver Bancorp (NASDAQ: CARVD) Torch Energy (NYSE: TRU) The Cash Store (NASDAQ: CSFS) Merriman Holdings (NASDAQ: MERR) (NASDAQ: YOKU) Stream Global Services (NYSE: SGS)
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid SmallCapNewsRelease one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation do no trading of any kind and send no Faxes or emails.


 Penny Stock

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.